Our industries
Pharmaceutical, healthcare and life sciences
We are recognised as a leading advisor for patent prosecution and litigation, corporate and licensing work in the pharmaceutical, healthcare and life sciences sectors.
Mayhar Mustafa Kazi
Our pharmaceutical, healthcare and life sciences team stays up-to-date with the rapidly changing landscape of these innovative sectors, advising research institutions, healthcare providers, medical device companies and major pharmaceutical players on the full spectrum of their legal concerns, including regulatory issues such as product registration, clinical trial regulation and marketing authorization applications.
Our IP expertise is designed to protect all aspects of our client’s portfolios. We advise on one-off filings, prosecution and litigation and assist with all aspects of our client’s IP strategies. Our expertise encompasses the full range of patents, trademarks and copyrights. Our clients are prominent international household names with diverse IP portfolios and leading local clients with strong brands nationally and in the region.
We handle various pharmaceutical, healthcare and life sciences advisory work, including compliance, risk management, and dispute resolution. Our experts also regularly defend doctors against malpractice claims, including Medicare/Medicaid and healthcare fraud and abuse. The team benefits from the presence of experienced medical, coding and billing experts.
Practice areas
- Drugs manufacturing and distribution
- Product licensing
- Regulatory compliance
- Commercial
At a glance
- Novartis Pharma Pakistan Limited: represented the client in suits and thereafter appeals filed by ex-employees before the District Courts and the High Court of Sindh bench at Larkana.
- Pakistan Chemists and Druggists Association: represented client and obtained an interim order restraining the operation of section 7 of the import pricing policy as issued by the Drug Regulatory Authority of Pakistan on behalf of the Defending American Life Insurance Company (Pakistan) Limited (ALICO Pakistan) (now known as IGI Life Insurance Limited) and American Life Insurance Company (ALICO) in two suits filed before the High Court of Sindh at Karachi by employees of American Life Insurance Company (Pakistan) Limited, against the intended sale of ALICO’s majority shareholding in ALICO Pakistan, to IGI Insurance Limited.
- Pfizer Corporation: represented the client in the restructuring and merger of its subsidiaries in Pakistan.
- Searle IV Solutions: represented client, one of the leading pharmaceutical companies of Pakistan manufacturing lifesaving IV solutions, in a suit relating to whether an S.R.O granting a tax exemption applied to the material imported by Searle.
News and insights
RIAA Advises on Acquisition of Novartis Pakistan by Getz Group – December 2025
Speak to lead pharmaceutical, healthcare and life sciences partner Mayhar Kazi today.
